Clinically Significant Transition Zone Prostate Cancer Detected by UroNav MRI/TRUS Fusion Biopsy in Active Surveillance Prostate Cancer PatientsSeptember 10, 2023Prostate CancerOncologyGenitourinary Cancer
Detection of Prostate Cancer in the Transitional Zone by Using a UroNav BiopsySeptember 10, 2023Prostate CancerGenitourinary CancerOncology
Reversal of Ptosis in Metastatic Prostatic Adenocarcinoma Presenting as Cavernous Sinus SyndromeSeptember 10, 2023Prostate CancerOncologyGenitourinary Cancer
BCR is unreliable surrogate for overall survival in prostate cancerSeptember 7, 2023Genitourinary CancerOncologyProstate Cancer
Predicting prostate cancer risk: Are polygenic risk scores ready for prime time?September 6, 2023Genitourinary CancerProstate Cancer
Improving Germline Genetic Testing Among Veterans With High Risk, Very High Risk and Metastatic Prostate CancerSeptember 6, 2023OncologyHematologyGenitourinary CancerProstate Cancer
Do AI chatbots give reliable answers on cancer? Yes and noSeptember 1, 2023Breast CancerLung CancerGenitourinary CancerMelanomaProstate Cancer
Urine test shows promise for diagnosing urothelial carcinomaAugust 30, 2023OncologyGenitourinary Cancer
FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancerAugust 14, 2023Genitourinary CancerProstate Cancer
How useful are circulating tumor cells for early diagnosis?August 9, 2023Breast CancerLung CancerGenitourinary Cancer
MRI-guided SBRT cuts radiation toxicity in prostate cancerJuly 26, 2023Genitourinary CancerProstate Cancer
‘Treatment holiday’ in prostate cancer with tailored dosingJuly 25, 2023Genitourinary CancerProstate Cancer
